JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (31)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Joshi, W.
Right arrow Articles by Thakkar, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Joshi, W.
Right arrow Articles by Thakkar, N.
Related Collections
Right arrow Pediatrics
Right arrow Pain
Right arrow Pharmacology

Anesth Analg 2003;97:35-38
© 2003 International Anesthesia Research Society

PEDIATRIC ANESTHESIA

An Evaluation of the Safety and Efficacy of Administering Rofecoxib for Postoperative Pain Management

Wandana Joshi, DO, Neil Roy Connelly, MD, Scott S. Reuben, MD, Marten Wolckenhaar, MD, and Nikhil Thakkar, MD

Department of Anesthesiology, Baystate Medical Center, Springfield, Massachusetts

Address correspondence and reprint requests to Neil Roy Connelly, MD, Department of Anesthesiology, Baystate Medical Center, 759 Chestnut St., Springfield, MA 01199. Address e-mail to neil.roy.connelly{at}bhs.org

The goal of our study was to evaluate the analgesic efficacy and safety of administering rofecoxib (1 mg/kg), a cyclo-oxygenase (COX)-2 selective nonsteroidal antiinflammatory drug, before pediatric tonsillectomy. Sixty-six patients, aged 3–11 yr, scheduled to undergo tonsillectomy received either placebo or rofecoxib (1 mg/kg). There were no significant differences between the two study groups with respect to demographics and blood loss. We found that the pain scores were significantly lower in the rofecoxib group compared with the control group at 2 h (P < 0.05) and 24 h (P < 0.006). The incidence of nausea (P < 0.03) and vomiting (P < 0.004) at home was more frequent in the control group than in the rofecoxib group. We conclude that a single preoperative dose of rofecoxib resulted in less vomiting and lower 24-h pain scores in pediatric patients undergoing an elective tonsillectomy.

IMPLICATIONS: In children undergoing tonsillectomy, a single preoperative dose of rofecoxib decreases 2- and 24-h pain and decreases nausea and vomiting at home.




This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
T. Sun, O. Sacan, P. F. White, J. Coleman, R. J. Rohrich, and J. M. Kenkel
Perioperative Versus Postoperative Celecoxib on Patient Outcomes After Major Plastic Surgery Procedures
Anesth. Analg., March 1, 2008; 106(3): 950 - 958.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
G. Riest, J. Peters, M. Weiss, S. Dreyer, P. D. Klassen, B. Stegen, A. Bello, and M. Eikermann
Preventive effects of perioperative parecoxib on post-discectomy pain
Br. J. Anaesth., February 1, 2008; 100(2): 256 - 262.
[Abstract] [Full Text] [PDF]

Home page
 J Child Health CareHome page
E. Idvall, C. Holm, and I. Runeson
Pain experiences and non-pharmacological strategies for pain management after tonsillectomy: a qualitative interview study of children and parents
J Child Health Care, September 1, 2005; 9(3): 196 - 207.
[Abstract] [PDF]

Home page
 Br J AnaesthHome page
P.-A. Lonnqvist and N. S. Morton
Postoperative analgesia in infants and children
Br. J. Anaesth., July 1, 2005; 95(1): 59 - 68.
[Full Text] [PDF]

Home page
 Anesth. Analg.Home page
A. Buvanendran, J. S. Kroin, K. J. Tuman, T. R. Lubenow, D. Elmofty, and P. Luk
Cerebrospinal Fluid and Plasma Pharmacokinetics of the Cyclooxygenase 2 Inhibitor Rofecoxib in Humans: Single and Multiple Oral Drug Administration
Anesth. Analg., May 1, 2005; 100(5): 1320 - 1324.
[Abstract] [Full Text] [PDF]

Home page
 EDUCATION AND PRACTICEHome page
S. Turner and V. Ford
Role of the selective cyclo-oxygenase-2 (COX-2) inhibitors in children
Arch. Dis. Child. Ed. Pract., October 1, 2004; 89(2): ep46 - ep49.
[Full Text] [PDF]

Home page
 Anesth. Analg.Home page
H. Ma, J. Tang, P. F. White, A. Zaentz, R. H. Wender, A. Sloninsky, R. Naruse, R. Kariger, R. Quon, D. Wood, et al.
Perioperative Rofecoxib Improves Early Recovery After Outpatient Herniorrhaphy
Anesth. Analg., April 1, 2004; 98(4): 970 - 975.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
E. D. Kharasch
Perioperative COX-2 Inhibitors: Knowledge and Challenges
Anesth. Analg., January 1, 2004; 98(1): 1 - 3.
[Full Text] [PDF]


Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2003 by the International Anesthesia Research Society.